Patrice D.
- Country
- France
- Department
- Service d'Endocrinologie, Maladies métaboliques, et Nutrition
Research Overview
- A Phase 4, Randomized, Open-Label, Active-Controlled Study to Investigate the Efficacy and Safety of Switching From Weekly Dulaglutide to Weekly Tirzepatide in Adults With Type 2 Diabetes
- Phase III Study of RO7795068 in Adults With Obesity or Overweight and Type 2 Diabetes
- Evaluation of Autologous Adipose Tissue-Derived Stromal Vascular Fraction Cells in Refractory Diabetic Foot Ulcers: A Phase II Multicenter Study
Data & Insights
Has run more than one trial at 133 of 567 partner sites.
Specializations
Cardiovascular Health
The investigator focuses on innovative approaches in heart failure prevention, particularly examining combination therapies with emerging cardiovascular agents. Their research explores protective strategies against cardiovascular death in high-risk populations.
- Heart Failure Risk Management
- Cardiovascular Prevention Strategies
- Combination Therapy Approaches
Diabetes Management
The investigator specializes in Type 2 diabetes treatment optimization, focusing on transitional therapy strategies and comparative effectiveness of different therapeutic agents. Their work examines innovative approaches to glycemic control through targeted interventions.
- Glycemic Control Optimization
- Treatment Transition Strategies
- Weekly Administration Therapies
Diabetic Complications
The investigator explores advanced therapeutic approaches for diabetic foot ulcers, including innovative cellular-based treatments. Their research investigates the application of autologous stromal vascular fraction in treating complex diabetic wounds.
- Advanced Wound Care
- Cellular-Based Therapies
- Refractory Ulcer Management
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.